New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system

Abstract

Abstract Glucagon-like peptide 1 is a neuromodulatory peptide that regulates the carbohydrate metabolism. It can cross the blood-brain barrier, and, indeed, while mostly produced in the distal small intestine and colon, it is also synthesized in the nucleus of the solitary tract of the brain stem. The wide distribution of glucagon-like peptide 1 receptors in the different areas of the brain is responsible for the pleiotropic effects of glucagon-like peptide 1 in the central nervous system. Notably, the peptide plays important roles in regulating food intake, in memory functioning, as well as in neuroprotective processes and emotions. This makes it an important tool in the treatment of many central nervous system related abnormalities, such as neurodegenerative diseases, addictions and neuropsychiatric disorders.